BostonGene-Integrated Genomic Registry (BIGR)

Description

The purpose of this project is to develop a comprehensive database of genomic, transcriptomic, molecular, and clinical characteristics of oncology patients to discover, define, and develop genomic and transcriptomic markers to improve future clinical outcomes across cancer types

Conditions

Malignancy

Talk to us

Study Overview

On this page

Study Details

Study overview

The purpose of this project is to develop a comprehensive database of genomic, transcriptomic, molecular, and clinical characteristics of oncology patients to discover, define, and develop genomic and transcriptomic markers to improve future clinical outcomes across cancer types

BostonGene-Integrated Genomic Registry Study

BostonGene-Integrated Genomic Registry (BIGR)

Condition
Malignancy
Intervention / Treatment

-

Contacts and Locations

Waltham

BostonGene, Waltham, Massachusetts, United States, 02453

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • 1. Suspected or confirmed malignancy
  • 2. Planned comprehensive genomic (\> 100 genes) and/or molecular analysis; or genomic and/or molecular data available from prior sequencing
  • 3. Baseline demographics and treatment information available
  • 4. Willingness for future contact by BIRG study personnel to provide information regarding associated cancer outcomes and treatment.
  • 5. Signed informed consent to participate in the study.
  • 6. Living in the United States at the time of enrollment

Ages Eligible for Study

18 Years to

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

BostonGene,

Nathan Fowler, PRINCIPAL_INVESTIGATOR, BostonGene

Study Record Dates

2036-07-01